scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1021777271 |
P356 | DOI | 10.1038/ONC.2013.213 |
P3181 | OpenCitations bibliographic resource ID | 1333214 |
P698 | PubMed publication ID | 23752197 |
P50 | author | Boris Zhivotovsky | Q30158891 |
Janne Lehtiö | Q37384646 | ||
Elena Panizza | Q41561985 | ||
P2093 | author name string | E Vernet | |
L M Orre | |||
T Gräslund | |||
V O Kaminskyy | |||
P2860 | cites work | Characterizing proteins and their interactions in cells and tissues using the in situ proximity ligation assay | Q24312603 |
Acetylation is indispensable for p53 activation | Q24313477 | ||
S100 proteins interact with the N-terminal domain of MDM2 | Q24336983 | ||
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2 | Q27642888 | ||
RING domain E3 ubiquitin ligases | Q27860546 | ||
Tumor suppressor p53 protein is a new target for the metastasis-associated Mts1/S100A4 protein: functional consequences of their interaction | Q28208109 | ||
Binding to intracellular targets of the metastasis-inducing protein, S100A4 (p9Ka) | Q28214677 | ||
DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2 | Q28254119 | ||
Divorcing ARF and p53: an unsettled case | Q28258356 | ||
p53 ubiquitination: Mdm2 and beyond | Q29619502 | ||
Overexpression of S100A4 in pancreatic ductal adenocarcinomas is associated with poor differentiation and DNA hypomethylation. | Q30795307 | ||
Self-association of calcium-binding protein S100A4 and metastasis | Q33569866 | ||
Proteins of the S100 family regulate the oligomerization of p53 tumor suppressor | Q33935212 | ||
From words to literature in structural proteomics | Q35084576 | ||
Overexpression of S100A4 is closely associated with progression of colorectal cancer | Q35435739 | ||
Calcium-dependent and -independent interactions of the S100 protein family. | Q36472950 | ||
Expression of S100A4, E-cadherin, alpha- and beta-catenin in breast cancer biopsies | Q36692461 | ||
Evaluation of potential interactions between the metastasis-associated protein S100A4 and the tumor suppressor protein p53. | Q37697035 | ||
Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer | Q38289312 | ||
Differential expression of S100A2 and S100A4 in lung adenocarcinomas: clinicopathological significance, relationship to p53 and identification of their target genes | Q38317520 | ||
Expression of S100A2 and S100A4 predicts for disease progression and patient survival in bladder cancer | Q38430923 | ||
Prognostic significance of calcium-binding protein S100A4 in colorectal cancer | Q38454622 | ||
Suppression of basal autophagy reduces lung cancer cell proliferation and enhances caspase-dependent and -independent apoptosis by stimulating ROS formation | Q39353049 | ||
Coexpression and nuclear colocalization of metastasis-promoting protein S100A4 and p53 without mutual regulation in colorectal carcinoma | Q39733928 | ||
Oligomerization conditions Mdm2-mediated efficient p53 polyubiquitylation but not its proteasomal degradation | Q39751187 | ||
p53 Oligomerization is essential for its C-terminal lysine acetylation | Q39902123 | ||
Up-regulation, modification, and translocation of S100A6 induced by exposure to ionizing radiation revealed by proteomics profiling | Q40085596 | ||
Hypomethylation-induced expression of S100A4 in endometrial carcinoma | Q40098520 | ||
Identification of protein-protein interactions using in vivo cross-linking and mass spectrometry | Q40493018 | ||
Modulation of the oligomerization state of p53 by differential binding of proteins of the S100 family to p53 monomers and tetramers | Q42285471 | ||
The C terminus of p53 binds the N-terminal domain of MDM2. | Q42532759 | ||
S100A4 (Mts1) gene overexpression is associated with invasion and metastasis of papillary thyroid carcinoma | Q43200588 | ||
Molecular basis of S100 proteins interacting with the p53 homologs p63 and p73. | Q43768901 | ||
Expression of S100A4 and Met: potential predictors for metastasis and survival in early-stage breast cancer. | Q45254364 | ||
Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53. | Q45345467 | ||
Overexpression of S100A4 is closely related to the aggressiveness of gastric cancer | Q47728151 | ||
The S100A4 Metastasis Factor Regulates Cellular Motility via a Direct Interaction with Myosin-IIA | Q56531468 | ||
Metastasis-associated protein Mts1 (S100A4) inhibits CK2-mediated phosphorylation and self-assembly of the heavy chain of nonmuscle myosin | Q63362549 | ||
Expression of S100A4 protein is associated with metastasis and reduced survival in human bladder cancer | Q63966034 | ||
Effect of mts1 (S100A4) expression on the progression of human breast cancer cells | Q71574517 | ||
Comparison of the metastasis-inducing protein S100A4 (p9ka) with other prognostic markers in human breast cancer | Q73645121 | ||
Nuclear localization of the metastasis-related protein S100A4 correlates with tumour stage in colorectal cancer | Q73750117 | ||
Differential expression of S100A2 and S100A4 during progression of human prostate adenocarcinoma | Q78729048 | ||
Metastasis-associated protein S100A4--a potential prognostic marker for colorectal cancer | Q83155625 | ||
Posttranslational modifications affect the interaction of S100 proteins with tumor suppressor p53 | Q84696189 | ||
P433 | issue | 49 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 5531-40 | |
P577 | publication date | 2013-12-05 | |
P1433 | published in | Oncogene | Q1568657 |
P1476 | title | S100A4 interacts with p53 in the nucleus and promotes p53 degradation | |
P478 | volume | 32 |
Q37694734 | Attenuation of cancer-initiating cells stemness properties by abrogating S100A4 calcium binding ability in head and neck cancers |
Q41661771 | Calcium-binding protein S100A4 confers mesenchymal progenitor cell fibrogenicity in idiopathic pulmonary fibrosis |
Q40859595 | Cancer-associated S100P protein binds and inactivates p53, permits therapy-induced senescence and supports chemoresistance |
Q38684881 | Cardioprotection by the transfer of coronary effluent from ischaemic preconditioned rat hearts: identification of cardioprotective humoral factors |
Q58614815 | Circulating S100 proteins effectively discriminate SLE patients from healthy controls: a cross-sectional study |
Q37554595 | Distinct prognostic values of S100 mRNA expression in breast cancer |
Q38836943 | Enrichment of nuclear S100A4 during G2/M in colorectal cancer cells: possible association with cyclin B1 and centrosomes |
Q64086388 | Expression profile and functional role of S100A14 in human cancer |
Q57456594 | Gene is Crucial for Methionine-Choline-Deficient Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice |
Q30276647 | Integrated genomic analysis of colorectal cancer progression reveals activation of EGFR through demethylation of the EREG promoter |
Q90703634 | Integrated nuclear proteomics and transcriptomics identifies S100A4 as a therapeutic target in acute myeloid leukemia |
Q48136210 | Interplay between Trx-1 and S100P promotes colorectal cancer cell epithelial-mesenchymal transition by up-regulating S100A4 through AKT activation |
Q33618652 | Involvement of AF1q/MLLT11 in the progression of ovarian cancer |
Q38734526 | Knockdown of S100A4 blocks growth and metastasis of anaplastic thyroid cancer cells in vitro and in vivo |
Q92994119 | Mts1 Up-regulation is Associated With Aggressive Pathological Features in Thyroid Cancer |
Q92186109 | Overexpressed methyltransferase-like 1 (METTL1) increased chemosensitivity of colon cancer cells to cisplatin by regulating miR-149-3p/S100A4/p53 axis |
Q37148928 | Prognostic significance of S100A4 expression in stage II and III colorectal cancer: results from a population-based series and a randomized phase III study on adjuvant chemotherapy |
Q96685990 | Proteomics pinpoints alterations in grade I meningiomas of male versus female patients |
Q34448984 | Role of Bruton's tyrosine kinase (BTK) in growth and metastasis of INA6 myeloma cells. |
Q55293322 | S100A16 up-regulates Oct4 and Nanog expression in cancer stem-like cells of Yumoto human cervical carcinoma cells. |
Q92458745 | S100A4 alters metabolism and promotes invasion of lung cancer cells by up-regulating mitochondrial complex I protein NDUFS2 |
Q38865767 | S100A4 and its role in metastasis – simulations of knockout and amplification of epithelial growth factor receptor and matrix metalloproteinases |
Q37376360 | S100A4 drives non-small cell lung cancer invasion, associates with poor prognosis, and is effectively targeted by the FDA-approved anti-helminthic agent niclosamide |
Q38296971 | S100A4 hypomethylation affects epithelial-mesenchymal transition partially induced by LMP2A in nasopharyngeal carcinoma |
Q49959205 | S100A4 promotes lung tumor development through β-catenin pathway-mediated autophagy inhibition. |
Q35079996 | S100A4 promotes pancreatic cancer progression through a dual signaling pathway mediated by Src and focal adhesion kinase. |
Q33720233 | Systems biology approaches to develop innovative strategies for lung cancer therapy |
Q57148077 | The expression of S100A4 protein in human intrahepatic cholangiocarcinoma: clinicopathologic significance and prognostic value |
Q40102636 | Underlying Mechanisms for Distant Metastasis - Molecular Biology |
Search more.